Key Updates in Non–Small Cell Lung Cancer Emerging From WCLC 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss updates in non–small cell lung cancer management emerging from World Conference on Lung Cancer 2025.

EP. 1: Treatment Decision-Making and Sequencing Factors in Advanced Non–Small Cell Lung Cancer

September 29th 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss treatment and sequencing considerations in advanced non–small cell lung cancer.

EP. 2: How Cemiplimab Plus Chemo Has Affected First-Line NSCLC Management, Including Squamous Histology

October 7th 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss the impact of the FDA approval of cemiplimab plus chemotherapy in advanced NSCLC.

EP. 3: Managing Immune-Related AEs in NSCLC

October 7th 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss the management of immune-related adverse effects in advanced NSCLC.

EP. 4: 5-Year EMPOWER-Lung 3 Data for Cemiplimab Plus Chemo in Advanced NSCLC

October 13th 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss 5-year data for cemiplimab plus chemotherapy in advanced NSCLC.

EP. 5: Navigating Immunotherapy in Advanced NSCLC After Early-Stage IO Therapy

October 13th 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss the use of immunotherapy after prior immunotherapy for early-stage NSCLC.

EP. 6: Eye-Catching Data From the 2025 World Conference on Lung Cancer

October 20th 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss key data from the 2025 World Conference on Lung Cancer.

EP. 7: Future Avenues of Research in Advanced NSCLC

October 20th 2025

Eric K. Singhi, MD, and Sandip P. Patel, MD, discuss future areas of research and unmet needs in non–small cell lung cancer.